MediWound Files Annual Report on Form 20-F YAVNE, Israel, March 5, 2026 — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (the “SEC”) on March 5, 2026. The annual report can be accessed on the SEC’s website at http://www.sec.gov, as well as via the Company’s investor relations website at http://ir.mediwound.com. The Company will provide a hard copy of its annual report on Form 20-F, including its audited financial statements, free of charge, to its shareholders upon request. Request should be directed in writing by email to jeremy@lifesciadvisors.com or by post to MediWound Ltd., 42 Hayarkon St., Yavne 8122745, Israel. About...

WEST PALM BEACH, Fla., March 05, 2026 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced the expansion of its senior secured revolving credit facility (the “Credit Facility”) with the addition of Customers Bank. Customers Bank has committed $25 million to the facility, bringing total committed capital to $165 million. The Credit Facility, originally established with East West Bancorp, Inc. in November 2024, remains expandable to $200 million, subject to certain conditions and additional lender participation. Proceeds from the Credit Facility will be used to finance the Company’s ongoing originations across its target CRE markets, fund future draws and unfunded commitments under existing loans, and manage liquidity...

NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) — GalaxyEdge Acquisition Corp (NYSE: GLEDU, the “Company”) announced today that it closed its initial public offering (“IPO”) of 10,000,000 units at an offering price of $10.00 per unit. The underwriters have a 45-day option from the date of the prospectus to purchase up to an additional 1,500,000 units from the Company at the IPO price to cover over-allotments, if any. Each unit consisting of one Class A ordinary share and one right to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of an initial business combination. The units are listed on The New York Stock Exchange (“NYSE”) and began trading under the ticker symbol “GLEDU” on March 4, 2026. Once the securities comprising the units begin separate trading, the ordinary share and rights are expected to be...

Late-breaking oral presentation to feature primary analysis from KYSA-8 registrational trial in stiff person syndrome (SPS) Oral presentation on updated KYSA-6 Phase 2 data in generalized myasthenia gravis (gMG) EMERYVILLE, Calif., March 05, 2026 (GLOBE NEWSWIRE) — Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today announced multiple abstracts selected for presentation at the American Academy of Neurology (AAN) Annual Meeting, taking place from April 18-22, 2026, in Chicago, IL. “Our presence at AAN marks an important milestone for Kyverna as we build upon miv-cel’s potential to redefine the treatment paradigm in both stiff person syndrome and myasthenia gravis,” said Warner Biddle, Chief Executive Officer of Kyverna Therapeutics....

SOUTHFIELD, Mich., March 05, 2026 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI) today announced the sale of its dataMate copper transceiver business to Bel Fuse Inc.® (NASDAQ: BELFA, BELFB), a leading global manufacturer of products that power, protect, and connect electronic circuits. The divestiture will enable Methode to sharpen the focus on key growth strategies, particularly in the area of power solutions, with a focus on data center business and power delivery and distribution products, anticipating the increasingly demanding requirements of very dense AI computing architectures. “This deal furthers our stated strategy of portfolio refinement and debt reduction while freeing resources for Methode to concentrate on its high-density power delivery products and streamline our facilities footprint,” said Jon DeGaynor,...

Liberty Ridge offers stunning homes on expansive home sites in a premier location near Lake Mead BOULDER CITY, Nev., March 05, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Las Vegas-area community, Liberty Ridge, is coming soon to Boulder City, Nevada. This exclusive community will feature two collections of stunning single-family homes on generous home sites, offering home shoppers a rare opportunity to own a new construction home in charming Boulder City. Site work is underway, and the community is anticipated to open for sale in summer 2026.Overlooking Boulder Creek Golf Club and only 15 minutes from scenic Lake Mead and the mighty Hoover Dam, Liberty Ridge is a community of rarely offered new homes in Boulder City. Two collections of stunning...